Results 141 to 150 of about 22,136 (209)

Preliminary Evidence for Sex Differences in CYP2C19 Metabolic Capacity During Psychotropic Drug Treatment. [PDF]

Genes (Basel)
Eiberger J, Weber H, Reif A, Deckert J, Walther S, Hahn M, Scherf-Clavel M.   +6 more
europepmc   +1 more source

Uncovering Modifiable Contributors to Depressive Symptoms During Antidepressant Prescription Renewal: A Primary Care Case Report. [PDF]

Clin Case Rep
Muhadri L, Phan H.
europepmc   +1 more source

Study on the Gut-Brain Mechanism of Escitalopram for Alleviating Symptoms of Disorders of Gut-Brain Interaction in the Elderly-A Cohort Study. [PDF]

J Clin Med
Tang Q, Li J.
europepmc   +1 more source

Efficacy and Safety of Escitalopram for Major Depressive Disorder in Children and Adolescents: A Systematic Review and Meta-Analysis with Age-Specific Findings. [PDF]

Neuropsychiatr Dis Treat
Maneeton B, Maneeton N, Pojanapotha P, Putthisri S, Oon-Arom A, Karawekpanyawong N, Kawilapat S, Maneeton P, Srichan K.   +8 more
europepmc   +1 more source

Placebo-controlled three-armed pilot trial of Escitalopram or Nortriptyline for depressive symptoms in Parkinson's disease (ADepT-PD). [PDF]

J Neural Transm (Vienna)
Schrag A, Embleton-Thirsk A, Carroll C, Serfaty M, Duncan G, Molloy S, Whipps J, McLennan B, Lewis G.   +8 more
europepmc   +1 more source

Sertraline and Escitalopram But Not Other Antidepressants Increase Acetylcholinesterase Activity <i>Ex Vivo</i> in the Rat Frontal Cortex. [PDF]

Ann Neurosci
Dharwadkar J, Nayak AR, Rao BSS, Srikumar BN.   +3 more
europepmc   +1 more source

Discovery of a potential novel pharmacogenomic biomarker on ANK3 gene for liafensine, a triple reuptake inhibitor for treatment-resistant depression. [PDF]

Transl Psychiatry
Luo W, Wang G, Whitaker JW, Dhali Z, Sun H, Lu H, Li X, Shi T, Zhang J.   +8 more
europepmc   +1 more source